Theraclion

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Real-time Euronext Paris Other stock markets 05:33:04 2024-06-13 EDT			5-day change	1st Jan Change
0.361 ^EUR	+0.28%		-2.43%	-6.96%

06-07	Theraclion: scientific publication hailed by stock market	CF
03-27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Theraclion Appoints Mehdi El Glaoui to Its Board of Directors

June 22, 2021 at 12:00 pm

THERACLION announced the arrival of a health specialist, Mehdi El Glaoui. He joins the board of directors and also invests 1.5% of the company's capital.

Latest news about Theraclion

Theraclion: scientific publication hailed by stock market	06-07	CF
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	23-10-24	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-11	CI
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1	23-09-27	CI
Theraclion: capital increase completed	23-06-23	CF
Theraclion SA announced that it has received â‚¬8.353961 million in funding from Furui Medical Science Company Luxembourg S.Ã r.l.	23-06-21	CI
Theraclion Names CEO	23-05-26	MT
Theraclion Appoints Martin Deterre as CEO	23-05-25	CI
Theraclion SA announced that it expects to receive €7 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	23-05-24	CI
Theraclion SA announced that it expects to receive ?12.649999 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	23-05-23	CI
Global markets live: HSBC, Logitech, Uber, IBM, BP...	23-05-02
Theraclion SA Auditor Raises 'Going Concern' Doubt	23-04-28	CI
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Theraclion: FDA approves pivotal study with Sonovein	23-04-18	CF
France's Theraclion Gets US FDA Nod for Clinical Trial of Varicose Veins Treatment	23-04-18	MT
Theraclion SA Announces US Food Drug Administration Approve Investigational Device Exemption Application to Initiate the Multi-Center Pivotal Study VEINRESET for the Treatment of Primary Insufficiency of Great Saphenous Veins with SONOVEIN	23-04-17	CI
Theraclion: boosted by positive results from US study	23-01-31	CF
Theraclion Announces Results of First US Trial	23-01-30	CI
Theraclion: partnership with the University of Virginia	22-12-22	CF
University of Virginia Cancer Center to Use Theraclion's HD Technology	22-12-21	CI
Theraclion SA Announces Last Patient of First Sonovein(R) US Study Has Been Treated	22-10-17	CI
Theraclion New Echotherapy for Varicose Veins Partnership with Parisian Region Hospital Wound Center Announced	22-09-29	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-26	CI
Theraclion SA Announces Revenue Result for the First Half of 2022	22-07-27	CI

Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of equipment (66.1%); - sale of consumables (27.8%); - provision of after-sales services (6.1%). Export accounts for 96.6% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-09-18 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERACLION	-6.96%	17.84M
THERMO FISHER SCIENTIFIC	+8.46%	220B
DANAHER CORPORATION	+14.38%	196B
INTUITIVE SURGICAL, INC.	+26.90%	152B
BOSTON SCIENTIFIC CORPORATION	+33.90%	114B
SIEMENS HEALTHINEERS AG	+3.54%	66.49B
EDWARDS LIFESCIENCES CORPORATION	+15.11%	52.89B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.93%	49.48B
AGILENT TECHNOLOGIES, INC.	-4.22%	38.85B
GE HEALTHCARE TECHNOLOGIES INC.	-1.75%	34.68B

Other Advanced Medical Equipment & Technology

Theraclion

Equities

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Theraclion Appoints Mehdi El Glaoui to Its Board of Directors

Latest news about Theraclion

Chart Theraclion

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology